Myelofibrosis Associated with Romiplostim Treatment in a Patient with Immune Thrombocytopenia

Figure 8

Marked hypercellular bone marrow for age (90% cellularity), with slight dyserythropoiesis (hematoxylin-eosin, original magnification × 40).